Every one of those 1 sits in a single category, regulation. Kratom is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are less corroborated than the beat average, carrying 2 original sources each against 3.1 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Senate Committee
Every one of those 1 sits in a single category, regulation. Kratom is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are less corroborated than the beat average, carrying 2 original sources each against 3.1 for the same window. Their average consequence score of 6 runs below the beat's 6.7 for that window. We currently track 1 Legal story that mention Senate Committee, all published on March 21, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 61 Legal stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Senate Committee. Shared-story counts are live from our verified record — not editorial picks.
A Senate committee has introduced legislation to regulate the sale and manufacturing of kratom, pivoting away from previous efforts to ban the substance. The bill establishes consumer safety standards, including age restrictions and mandatory purity testing, aligning with the national 'Kratom Consumer Protection Act' movement.